- 건국대학교

	Konkuk University Medical School Opens Research Center to Study Toll-like Receptors
	관리자		774		2016.09.30

<img alt="" src="ArticleFile.do?id=11673561" />
On September 23, 2016, Konkuk University (KU) established a research center to study toll-like receptors (TLRs), which are a type of proteins that play a role in host defense from infections. The research center is expected to study TLR-based networks and develop treatments for cancer and brain diseases. It is part of the Medical Research Center (MRC) project sponsored by the National Research Foundation of Korea.
The opening ceremony was held at The Classic 500 and KU Foundation Chairperson Kyunghee Kim, President Sang-Gi Min, Executive Vice President for Medicine Seolhee Han, and KU Medical Center Executive Director Jung-hyun Yang attended the event. Special guests included National Science and Engineering Programs Director Sang-yub Lee and Division of Medical Sciences Director Hoiyoung Lee from the National Research Foundation of Korea, CEO of Dynebio Jehyun Lee, and CEO of Kang Stem Biotech Research Director Gwang-won Seo as well as other experts in the pharmaceutical and biotechnology industries.
“KU’s medical school was selected for the MRC project through heavy investment and inviting authorities in research,” said Chairperson Kim in her congratulatory remarks. “I hope that translational research connecting basic sciences and clinical applications can take place at the research center.”
“Research at the center will be instrumental in developing drugs for hard-to-cure diseases, such as cancer, infections, and genetic diseases,” said President Min. “I hope that through the project Konkuk University can enhance its research capacity at the national level and become globally competitive as well as contribute to the development of the pharmaceutical industry.”

	KJH_9364.jpg (210,882)
	KU to Participate in Embedded...
	Konkuk University Establishes...